REGISTERED
on 30 Aug 2022
Last Applicant/ Owned by
SUITE 1200
SEATTLE
WA
98109
Serial Number
88569196 filed on 07th Aug 2019
Registration Number
6834335 registered on 30th Aug 2022
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
BREYANZI
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
First Use Date in General
05th Feb 2021
First Use Date in Commerce
05th Feb 2021
Mark Details
Serial Number
No 88569196
Mark Type
No Service/Collective Mark
Attorney Docket Number
No CELG1977US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.05 -
Circles made of broken or dotted lines
26.01.11 -
Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 26th Jul 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 25th Jul 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th Jun 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 15th Jun 2022 | USE AMENDMENT FILED |
| 15th Jun 2022 | TEAS STATEMENT OF USE RECEIVED |
| 14th Dec 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Dec 2021 | SOU EXTENSION 4 GRANTED |
| 10th Dec 2021 | SOU EXTENSION 4 FILED |